The company, founded by a group of former scientists at Unipath, is responsible for creating leading digital fertility and pregnancy tests such as Clearblue, as well as other women’s health diagnostics.

Concepta will now develop and market a diagnostic device that can accurately and simultaneously test for fertility and pregnancy, as well as monitor early stage pregnancy health.

The firm has also just announced several new appointments with former CEO of Axis-Shield Dr Ian Gilham joining as Chairman, and lead equity investor David Evans joining as a board director.